In contrast, STS patients exhibited a significant increase in the frequency of NK cells expressing NKp44, particularly within the CD56dim subset, possibly reflecting persistent stimulation or activation of NK cells in response to tumor signals and suggesting an altered activation state in these patients. This evidence concerns the gene NCR2 and neoplasm.